Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-28

Clinical Trial Update: To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing Geneva's 10 mg glipizide tablets to Roerig's Glucotrol 10 mg tablets to establish relative bioequivalence in type 2 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)
  • Glucotrol (glipizide)

Snippet

Sponsor: Sandoz | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED